What is Aspira Pathlab & Diagnostics share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Aspira Pathlab & Diagnostics?

The latest standalone P/E ratio of Aspira Pathlab & Diagnostics as of 20-Dec-2024 is 0.00.

What is the P/B ratio of Aspira Pathlab & Diagnostics?

The latest standalone P/B ratio of Aspira Pathlab & Diagnostics as of 20-Dec-2024 is 5.75.

Aspira Pathlab & Diagnostics Ltd - Stock Valuation and Financial Performance

Name: Aspira Pathlab & Diagnostics
Brand: Aspira Pathlab & Diagnostics

BSE: 540788 | NSE: | Hospital & Healthcare Services | Small Cap

Place order

Aspira Pathlab&Diagn Share Price

₹62.10 -0.10 -0.16%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Aspira Pathlab&Diagn

Based on:

Data

M-Cap below 100cr DeciZen not available

Aspira Pathlab & Diagnostics stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

63.9 Cr.

52-wk low:

52-wk high:

79.7

Is Aspira Pathlab & Diagnostics Ltd an attractive stock to invest in?

1. Is Aspira Pathlab & Diagnostics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aspira Pathlab & Diagnostics Ltd is a below average quality company.

2. Is Aspira Pathlab & Diagnostics Ltd undervalued or overvalued?

The key valuation ratios of Aspira Pathlab & Diagnostics Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Aspira Pathlab & Diagnostics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Aspira Pathlab & Diagnostics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aspira Pathlab&Diagn:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	4%	1.8%	-25.4%	-38.4%	-34.5%	-26.3%	21.5%	41.6%	2.4%	-18.5%	-
Value Creation Index ⓘ	-0.7	-0.9	-2.8	-3.7	-3.5	-2.9	0.5	2.0	-0.8	-2.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0.8	4.4	7.6	8.4	15.2	19.5	14.5	13.2	18
Sales YoY Gr.	-	NA	NA	473.7%	75.2%	10.2%	80.6%	28.5%	-26%	-8.7%	-
Adj EPS ⓘ	0.1	0.1	-5.3	-10.8	-6.3	-4.6	1.3	4.3	-0.1	-2.6	-0.3
YoY Gr.	-	33.3%	-4475%	NA	NA	NA	NA	223.1%	-102.1%	NA	-
BVPS (₹) ⓘ	16.1	16.2	11.4	0.6	6.3	4.1	8.1	12.4	12.4	9.9	10.8
Adj Net Profit ⓘ	0	0	-2.7	-5.6	-5.2	-4.2	1.4	4.5	-0.1	-2.7	0
Cash Flow from Ops. ⓘ	0	-0.4	-1.3	-4.8	-3.4	-1.9	5.7	2	0	1.1	-
Debt/CF from Ops. ⓘ	0	-7.2	-5.7	-2.4	-2.2	-4.2	0.2	0.4	-80.2	1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	11.6%	-4.6%	-8.7%
Adj EPS ⓘ	-245.3%	NA	-224.7%	NA
BVPSⓘ	-5.3%	9.2%	6.8%	-20.5%
Share Price	-	11.2%	-9.3%	58.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	0.9	0.8	-57	-178.6	-187.6	-94.3	22.8	42.3	-0.7	-23.3	-2.6
Op. Profit Mgn % ⓘ	0	0	-339.5	-88.9	-42.5	-21.7	23.1	32.3	11	-9	6.7
Net Profit Mgn % ⓘ	0	0	-359.1	-128.1	-67.9	-50.4	9.1	22.8	-0.6	-20.2	-1.5
Debt to Equity ⓘ	0	0.7	1.2	33.9	1.5	2	0.2	0.1	0.1	0.1	0.1
Working Cap Days ⓘ	0	0	1,188	353	244	224	89	91	175	187	47
Cash Conv. Cycle ⓘ	0	0	40	25	32	29	17	45	80	58	26

Recent Performance Summary

Sales growth is good in last 4 quarters at 38.95%

Return on Equity is Poor

Sales growth has been subdued in last 3 years -4.61%

Latest Financials - Aspira Pathlab & Diagnostics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.3	-
TTM Sales (₹ Cr.)	18.1	-
BVPS (₹.) ⓘ	10.8	-
Reserves (₹ Cr.) ⓘ	1	-
P/BV ⓘ	5.75	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	25.00 / 79.70
All Time Low / High (₹)	14.15 / 124.15
Market Cap (₹ Cr.)	63.9
Equity (₹ Cr.)	10.3
Face Value (₹)	10
Industry PE ⓘ	43.2

Management X-Ray of Aspira Pathlab&Diagn:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Aspira Pathlab&Diagn

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Aspira Pathlab&Diagn

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0	0	0.76	4.36	7.64	8.42	15.21	19.54	14.46	13.20
Operating Expenses ⓘ	0.13	0.23	3.34	8.23	10.88	10.24	11.69	13.23	12.86	14.39
Manufacturing Costs	0	0.03	0.20	0.65	0.84	0.83	2.48	1.78	1.08	1.25
Material Costs	0	0	0.14	1.30	2.26	1.99	2.63	3.14	2.50	2.62
Employee Cost	0	0.08	1.61	3.42	4.47	4.95	4.03	5.02	5.59	6.20
Other Costs ⓘ	0.12	0.13	1.38	2.85	3.31	2.48	2.55	3.29	3.70	4.32
Operating Profit ⓘ	-0.13	-0.23	-2.58	-3.87	-3.25	-1.83	3.51	6.32	1.59	-1.19
Operating Profit Margin (%)	-	-	-339.0%	-88.9%	-42.5%	-21.7%	23.1%	32.3%	11.0%	-9.0%
Other Income ⓘ	0.21	0.32	0.31	0.22	0.25	0.29	0.20	0.15	0.32	0.42
Interest ⓘ	0.02	0.05	0.26	0.80	0.96	1.01	0.89	0.37	0.42	0.37
Depreciation ⓘ	0	0	0.20	1.12	1.23	1.66	1.44	1.64	1.59	1.54
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.07	0.04	-2.72	-5.58	-5.18	-4.21	1.38	4.46	-0.09	-2.67
Tax ⓘ	0.04	0.01	0	0	0	0.03	0	0	0	0
Profit After Tax	0.02	0.03	-2.72	-5.58	-5.18	-4.24	1.38	4.46	-0.09	-2.67
PAT Margin (%)	-	-	-359.0%	-128.0%	-67.9%	-50.4%	9.1%	22.8%	-0.6%	-20.2%
Adjusted EPS (₹)	0.1	0.1	-5.3	-10.8	-6.3	-4.6	1.3	4.3	-0.1	-2.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	3.61	3.64	5.92	0.33	5.19	3.80	8.31	12.79	12.75	10.14
Share Capital ⓘ	2.25	2.25	5.19	5.19	8.19	9.29	10.29	10.29	10.29	10.29
Reserves ⓘ	1.36	1.39	0.72	-4.86	-3	-5.49	-1.98	2.50	2.46	-0.15
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	2.62	6.79	10.59	6.75	6.87	0.77	0.86	0.96	1.08
Long Term Debt	0	0	3.17	10.50	4.78	4.55	0.77	0.86	0.96	1.08
Short Term Debt	0	2.62	3.61	0.09	1.96	2.32	0	0	0	0
Trade Payables	0	0	0.29	0.23	0.29	0.40	0.66	0.61	0.35	0.73
Others Liabilities ⓘ	0.21	0.03	1.87	1.38	2.57	3.26	2.03	3.88	3.28	2.76
Total Liabilities ⓘ	3.82	6.30	14.86	12.53	14.80	14.34	11.78	18.14	17.34	14.71
Fixed Assets
Gross Block	0	0.04	7.99	9.23	11.45	12.91	13.41	16.87	16.88	17.20
Accumulated Depreciation	0	0	0.20	1.33	2.55	4.21	5.66	7.29	8.88	10.41
Net Fixed Assetsⓘ	0	0.04	7.79	7.91	8.90	8.70	7.75	9.57	8.01	6.79
CWIP ⓘ	0	0	0.25	0	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0	0	0.12	0.37	0.28	0.28	0.37	0.40	0.40	0.45
Trade Receivables	0.15	0.06	0.09	0.35	0.80	0.60	1.70	4.49	2.34	2.24
Cash Equivalents	3.08	5.33	2.81	0.22	0.10	1.10	1.19	1.64	2.35	1.38
Others Assetsⓘ	0.59	0.87	3.81	3.68	4.73	3.66	0.77	2.02	4.25	3.85
Total Assets ⓘ	3.82	6.30	14.86	12.53	14.80	14.34	11.78	18.14	17.34	14.71

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	0	-0.37	-1.29	-4.81	-3.39	-1.87	5.67	2.03	-0.01	1.05
PBT ⓘ	0.07	0.04	-2.72	-5.58	-5.18	-4.21	1.38	4.46	-0.09	-2.67
Adjustment ⓘ	-0.03	-0.02	0.15	1.71	1.99	2.40	2.36	2.40	1.80	1.77
Changes in Working Capital ⓘ	-0.01	-0.33	1.29	-0.94	-0.19	-0.03	1.93	-4.83	-1.73	1.96
Tax Paid ⓘ	-0.02	-0.05	0	0	0	-0.03	0	0	0	0
Cash Flow From Investing Activity ⓘ	0.08	-0.02	-10.14	-0.77	-1.97	0.24	-0.09	-0.51	0.16	0.14
Capex	0	-0.04	-8.20	-1	-0.51	-0.05	-0.30	-0.61	-0.13	-0.26
Net Investments	0.01	0	-2.25	0	-1.71	0	0	0	0	0
Others ⓘ	0.08	0.02	0.31	0.22	0.25	0.29	0.20	0.09	0.29	0.40
Cash Flow From Financing Activityⓘ	2.96	2.64	8.91	6.52	3.35	1.27	-2.17	-1.35	-0.94	-0.95
Net Proceeds from Shares ⓘ	2.96	0	5	0	5.10	2.86	3	0	0	0
Net Proceeds from Borrowing ⓘ	0	2.62	3.17	7.33	-6.29	-0.23	-3.78	0.09	0.10	0.12
Interest Paid ⓘ	0	0	-0.26	-0.80	-0.96	-1.01	-0.89	-0.37	-0.42	-0.37
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.01	0.99	0	5.50	-0.34	-0.50	-1.07	-0.62	-0.70
Net Cash Flow ⓘ	3.05	2.25	-2.52	0.94	-2	-0.35	3.41	0.17	-0.79	0.24

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	1.1	0.76	-57.04	-178.61	-187.57	-94.32	22.8	42.26	-0.69	-23.34
ROCE (%)	3.95	1.78	-25.35	-38.38	-34.5	-26.3	21.52	41.63	2.4	-18.49
Asset Turnover Ratio	0	0	0.07	0.32	0.56	0.58	1.16	1.31	0.82	0.82
PAT to CFO Conversion(x)	0	-12.33	N/A	N/A	N/A	N/A	4.11	0.46	N/A	N/A
Working Capital Days
Receivable Days	0	0	35	19	28	30	28	58	86	63
Inventory Days	0	0	57	20	16	12	8	7	10	12
Payable Days	0	0	736	72	42	63	74	74	70	75

Aspira Pathlab & Diagnostics Ltd Stock News

Aspira Pathlab & Diagnostics Ltd FAQs

What is the share price of Aspira Pathlab&Diagn?

Company share prices are keep on changing according to the market conditions. The closing price of Aspira Pathlab&Diagn on 20-Dec-2024 16:59 is ₹62.10.

What is the market cap of Aspira Pathlab&Diagn?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Aspira Pathlab&Diagn stood at ₹63.92.

What is the P/E ratio of Aspira Pathlab&Diagn?

The latest P/E ratio of Aspira Pathlab&Diagn as of 20-Dec-2024 16:59 is 0.00.

What is the P/B ratio of Aspira Pathlab&Diagn?

The latest P/B ratio of Aspira Pathlab&Diagn as of 20-Dec-2024 16:59 is 5.75.

What is the 52-week high and low of Aspira Pathlab&Diagn?

The 52-week high of Aspira Pathlab&Diagn is ₹79.70 and the 52-week low is ₹25.00.

What is the TTM revenue of Aspira Pathlab&Diagn?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aspira Pathlab&Diagn is ₹18.09 ( Cr.) .

About Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited is a public limited company incorporated and domiciled in India. The company is engaged in the business of running, owning, managing and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.

It has its registered office at Shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopar (West) Mumbai, Maharashtra, India.

The Board of Directors of the Company, which has been identified as being the chief operating decision maker (CODM), evaluates the Company’s performance, allocate resources based on the analysis of the various performance indicator of the Company as a single unit.

Business area of the company

The Company is solely engaged in the business of running laboratories for carrying out Pathological investigations in various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations.